American Psychiatric Association – författare

Mini-D 5, diagnostiska kriterier enligt DSM-5-TR, ger en välunderbyggd och samlad konsensusbild av aktuell kunskap om de mest framträdande och relevanta symtomen vid de olika formerna av psykiska störningar och sjukdomar.Ett grundsyfte med kriteriesystemet är att underlätta kommunikation mellan olika vårdgivare rörande diagnostik av psykiska störningar och sjukdomar. Tanken är emellertid inte att systemet med dess symtombeskrivande kriterier ska ersätta patientens personliga berättelse. Via berättelsen tillkommer sådan bakgrundsinformation som i de flesta fall har avgörande betydelse för möjligheterna att kunna fastställa en psykiatrisk diagnos.I den nu aktuella utgåvan följer kodklassifikationen klassifikationssystemet i ICD-10-CM. Det är en mer detaljerad amerikansk utgåva av WHO:s system ICD-10. I Sverige används för närvarande ICD-10-SE som liksom den amerikanska utgåvan inkluderar vissa tillägg. Men diagnoskoderna i Mini-D 5 som bygger på den amerikanska versionen är så gott som helt överensstämmande med de koder som används i Sverige, vilket är en praktisk fördel.

De mest framträdande förändringar som gjorts i den nya utgåvan är i korthet följande:

Viktiga justeringar av kriterieformuleringar har gjorts i fler än 70 diagnoser. Förlängd sorgreaktion har dessutom tillkommit som en ny diagnos.

Bruksanvisningen har skärpts upp under rubrikerna "Tillvägagångssätt vid kliniska ärendebeskrivningar" och "Kliniskt omdöme". Budskapet är att ett professionellt bruk av DSM som stöd i diagnostiken förutsätter såväl kunskaper i psykiatri som praktisk klinisk erfarenhet och gott kliniskt omdöme.

Kapitlet om "Läkemedelsbetingade motoriska störningar och andra läkemedelsbiverkningar" har utökats rejält. I synnerhet möjliga motoriska biverkningar beskrivs utförligt med referens till ett flertal olika läkemedel som potentiellt kan framkalla sådana biverkningar.

The is a compilation of articles from Hospital and Community Psychiatry on the management of the violent patient.

In recent years, patients, lay publications, and consumer groups have expressed concern about whether benzodiazepines are overprescribed. Psychiatrists have raised questions about the potential for these medications-especially some of the newer, high-potency, short half-life compounds—to produce serious side effects as well as to induce drug dependence.

Benzodiazepine Dependence, Toxicity, and Abuse provides clinicians with a review of the available information on the potential hazards of benzodiazepine treatment and offers suggestions for the rational prescription of these medications.

This handbook provides clinicians with timely and useful information that will help psychiatrists obtain optimal coverage of services for patients. Among the issues addressed are frequently encountered problems, confidentiality, contracting, and the process of utilization management.

The original task force report, completed in the summer of 1994, reflected the current state of addiction treatment and provided recommendations for improving these services in the future. That monograph is reproduced in this book, which accomplishes the following: • Define psychiatrists' current roles and practices in the treatment of substance-dependent patients in relationship to that of other practitioners, with particular attention to issues such as dual diagnosis, methadone treatment, and detoxification• Develop suggestions for appropriate funding mechanisms for the payment of addicted patients' treatment in the context of managed care and indemnity benefit programs• Examine issues related to the funding of public sector programs, including funding of Department of Veterans Affairs programs, block grant funding of state and city programs, as well as funding of voluntary treatment programs within and outside the criminal justice system.

This book is divided into four sections. Chapter 1 reviews the history of American psychiatry's interest in addiction disorders and the development of the current network of addiction treatment services. Chapter 2 is a snapshot of the current addiction treatment system, with a description of the services provided in general medical settings, psychiatric hospitals, freestanding residential facilities, and private practice and other outpatient settings. Chapter 3 explores the economics of the treatment system: the costs of addictive diseases to American society and the costs and sources of support for their treatment. Chapter 4 examines the range of system modifications and resource allocations needed to bring high quality, cost-effective treatment to addicted patients and their families. These needs range from improving data collection and treatment research to increasing community involvement and the application of current research findings.

The shifting demographic toward a "graying" population-coupled with today's reality of managed care—makes the need for high-quality, cost-effective psychiatric services within the nursing care setting more urgent than ever. As we increase the number of our years, it is also imperative that we enhance the quality of those years.

The product of the American Psychiatric Association's (APA's) Council on Aging and its Committee on Long-Term Care and of the Elderly, the Manual of Nursing Home Practice for Psychiatrists stands out because it focuses on the "how"—not the "why"—of nursing home care. Of exceptional importance is its detailed discussion of the Minimum Data Set (MDS), a structured assessment required by both Medicare and Medicaid for all residents of skilled nursing facilities.

Divided into six sections, this "how to" volume contains practical information readers can use right away, from getting reimbursed by insurance companies to handling nursing facility politics: • Clinical—History; evaluation and management of psychiatric problems in long-term care patients; an overview of the MDS; sexuality within the nursing home care setting• Regulatory—Introduction to the Nursing Home Reform Act of 1987 (part of OBRA-87) and its implications for psychiatric care; details about the Resident Assessment Instrument (RAI), which includes the MDS, the Resident Assessment Protocols (RAPs), and Utilization Guides specified in the State Operations Manual (SOP)• Financial—Documentation, reimbursement, and coding; what to look for when contracting with nursing homes• Legal and ethical—The dehumanizing effect of diagnostic labels and the ethical issues inherent in regulating daily schedules (e.g., bed, meal, and bath times); nursing home placement; competence and decision-making ability; comfort care for end-stage dementia; coping with Alzheimer's disease; and the role of caregivers• Summary and Future Perspectives—A detailed vision about how psychiatrists can improve the diagnosis and treatment of nursing home patients• Appendixes and bibliography—Staffing recommendations and assessment instruments

Edited by a distinguished authority and former chair of the APA's Committee on Long-Term Care and Treatment of the Elderly, this comprehensive volume will appeal to a wide audience of professionals: from general psychiatrists, nurse practitioners, and clinical nurse specialists, to primary care physicians and residents.

The book discusses depression, its symptoms, causes, treatment and phases, medications, and suicide risk. This is a package of 5.

In questions of psychiatric ethics, simple "yes" or "no" answers are rare, yet questions arise frequently in the clinical setting. "Should I accept a patient's invitation to a party?" "Is it OK to tell a patient that I, too, have had a depression?" "Can I release sensitive information about my patient without the patient's consent?" "Can I give a psychiatric opinion about someone I've never examined?"

A shortage of ethics instruction from medical school through residency has left many psychiatrists facing the increasingly complex field of ethics without a clear guide to ethical decision making and conductuntil now.

Informed by some of the formal proceedings of the APA Ethics Committee, Ethics Primer of the American Psychiatric Association presents today's ethical dilemmas in eleven informative chapters-brought to life by the clinical vignettes based on actual cases seen by this primer's distinguished contributors. • Boundary violations between the doctor—patient relationship and any other relationship (e.g., social, sexual/romantic, business)• Issues such as informed consent, psychopharmacology, hospitalization, and psychotherapy with children, adolescents, and families• Issues such as confidentiality, competence and consent, quality of life, abuse and neglect, and use of restraints with geriatric populations • Involuntary hospitalization rife with conflict and controversy where many ethical principles clash (e.g., beneficence, autonomy, informed consent)• Reconciling ethical conduct (as delineated in guidelines of the AMA, APA, and Sabin) with managed care's cost containment and rationing of medical services• Confidentiality, how this fundamental ethics principle can clash with the business ethics of managed care and insurance companies• Gifts from patients and industry when and why they are or are not acceptable• The often uncomfortable duty to report colleagues who engage in fraud or deception, from speaking privately with a colleague to referring a concern to a departmental committee, supervisor, or local APA ethics committee (and applicable legal mandates)• Emergency care ethics how to ensure proper treatment for psychiatric patients who come to the emergency room with physical illnesses forensic psychiatry, including codes of ethics, boundary issues, and management of allegations of ethical misconduct• When consultations and second opinions are needed

Including an appendix with selected material from The Principles of Medical Ethics With Annotations Especially Applicable to Psychiatry, this clinical guide and reference is sure to stimulate the discussion so integral to maintaining the dynamic tradition of ethics. As such, it is essential reading for every psychiatrist—whether in training or in established clinical practice—who aspires to a richer appreciation for the wisdom and subtleties of the guidelines and principles of medical ethics.